Highlights Abivax

Equities

ABVX

FR0012333284

Market Closed - Euronext Paris Other stock markets 11:35:18 2024-06-04 am EDT			After market 03:46:25 pm
12.26 ^EUR	-2.08%		12.3	+0.33%

May. 20	BTIG Initiates Abivax at Buy Rating With $43 Price Target	MT
May. 08	Abivax: four abstracts to be presented on obefazimod	CF

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Abivax: four abstracts to be presented on obefazimod	May. 08	CF
Abivax SA Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Preclinical Colon Cancer Model At Digestive Disease Week 2024	May. 08	CI
ABIVAX Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 02	CI
Abivax Announces Update to Obefazimod Phase 2B Clinical Development Program in Moderately to Severely Active Crohn?s Disease	Feb. 02	CI
Abivax to Host KOL Investor Event to Review Phase 2B Clinical Data and Phase 3 Trial Design for Obefazimod in Patients with Moderately to Severely Active Ulcerative Colitis	Jan. 24	CI
Abivax: share price rises after strategic update	Jan. 22	CF
Abivax Raises $235.8 Million via Nasdaq IPO	23-10-24	MT
Abivax Closes Nasdaq IPO With $235.8 Million in Gross Proceeds	23-10-24	MT
Abivax Prices Nasdaq IPO; Trading Resumes in Paris	23-10-20	MT
Abivax: difficult debut for biotech on Nasdaq	23-10-20	CF
Abivax: Nasdaq IPO price at bottom of range	23-10-20	CF
Abivax Shares Temporarily Suspended from Trading on Euronext Paris	23-10-20	MT
Abivax Sets Price Range for Public Offering of American Depositary Shares in US	23-10-19	MT
Abivax Files for Public Offering of American Depositary Shares in US	23-10-02	MT
ABIVAX Société Anonyme has filed an IPO in the amount of $100 million.	23-09-29	CI
ABIVAX Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-21	CI
Abivax appoints head of investor relations	23-08-24	CF
Valneva: up sharply after positive analysis	23-06-16	CF
Abivax appoints new HR Director	23-06-08	CF
ABIVAX Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Abivax

Equities

ABVX

FR0012333284

Highlights

Filters